The data set is derived from a cross-sectional survey among 150 multi-drug resistant tuberculosis (MDR-TB) in-patients in the National Institute of Diseases of the Chest and Hospital (NIDCH) in Dhaka, Bangladesh. The aims of the study were to statistically validate the PHQ-9 depression screening tool among MDR-TB in-patients within this context, measure the prevalence of depression among MDR-TB in-patients within this context, and explore the associations between socio-demographic and health related variables and depression status among MDR-TB in-patients within this context. The data were collected in 2018 from all consenting in-patients between January and July 2018. The data includes socio-demographic variables, self-report details of co-morbidities and responses to the PHQ9 question-set for depression. The PHQ-9 assessments were repeated after two weeks to assess the tool’s consistency over time. Also as part of the validation of PHQ-9, within a two-week period a psychiatrist assessed depression among patients using the Structured Clinical Interview for Depression (SCID DSM-IV). These results are also included in the data set to serve as a “gold standard” for the PHQ-9 validation. Two patients left (without being discharged) the hospital before the SCID interview could be conducted, so the SCID data is only available for 148 of the 150 respondents.
External deposit with Research Data Leeds.